alnylam
Alnylam Pharmaceuticals is seeking a scientist to support clinical-stage programs within Analytical Sciences. The role involves developing and transferring analytical assays, authoring regulatory documents, and providing technical review of GMP data to support early-stage clinical programs, particularly focusing on chromatographic and LCMS methods for oligonucleotides.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
Right around the average for this role
Associate Scientist II, Analytical Development
Vaxcyte
Associate R&D - Analytical
Elanco
Analytical Chemist, Cell & Gene Therapy Products – Bioproduct Research and Development
Eli Lilly and Company
12 Month – Work Placement Student - Analytical Chemistry
AstraZeneca
Analytical Development Chemist
Eurofins
Entry Level Analytical Chemist
Eurofins